Board Member
Talphera, Inc. (TLPH)Equibles does not estimate personal net worth.
Mark Wan is recorded as Board Member at Talphera, Inc. (TLPH) since June 22, 2026. Talphera, Inc. reported in an 8-K filed June 23, 2026 that Mark Wan was appointed Class III director, effective June 22, 2026. Talphera, Inc. reported in an 8-K filed October 10, 2023 that Mark Wan was appointed Class III director, effective October 10, 2023. Talphera, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Talphera, Inc. includes Vincent Angotti (CEO and Board Member), Vincent J. Angotti (CEO and Board Member), Raffi Asadorian (CFO) and 7 others.
“Marina Bozilenko, Joseph Todisco and Mark Wan were elected as Class III directors, by a plurality of the votes entitled to vote on the election of directors, to hold office until the 2029 Annual Meeting of Stockholders by the following vote:”
“Marina Bozilenko, Howard B. Rosen and Mark Wan were elected as Class III directors, by a plurality of the votes entitled to vote on the election of directors, to hold office until the 2026 Annual Meeting of Stockholders by the following vote:”
2026-06-22–present
TLPH
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2026-06-22–present
